Creo Medical Group Plc (CREO) Ord GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




13.25p
13.50p
33.00p
£52.07 million
13.25p
12.25p
9.30p
n/a
0.38p (2.91%) Previous:
0.38p
808,279
n/a
30,000
Performance
1 week 1W | 7.07% | 1 year 1Y | 59.54% |
---|---|---|---|
1 month 1M | 3.64% | 2 years 2Y | 59.85% |
3 months 3M | 34.52% | 3 years 3Y | 82.94% |
6 months 6M | 28.38% | 5 years 5Y | 92.77% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 4.00 | 4.00 |
Profit before tax (£m) | (29.00) | (26.40) |
Adjusted EPS (p): | (8.00) | (8.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical's SpydrBlade Flex device receives US FDA clearance
11 June 2025 07:44
-
Creo Medical eyes transition to full commercialisation in FY25
17 February 2025 08:00
-
Director dealings: Creo Medical chairman raises stake
16 December 2024 15:27
-
MicroBlate™ Flex begins lung tumour clinical study
10 July 2025 07:00
-
PDMR Options Revision
9 July 2025 09:41
-
Change of Nominated Adviser
30 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.